supplier
Qdem Pharmaceuticals Limited
as a supplier
6 recorded awards from 3 buyers , between 21 Dec 2020 and 23 Apr 2023.
awards won
6
exclusive
0%
0 sole-winner awards
median award
£12.3m
largest
£12.3m
“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.
sells to
| buyer | awards |
|---|---|
| NHS England | 3 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | 2 |
| The NHS Commissioning Board (operating under the name of NHS England) | 1 |
contracts won
| contract | buyer | value | awarded |
|---|---|---|---|
| NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared | NHS England | £304,504,000 | 23 Apr 2023 |
| NHS National Generic Pharmaceuticals Interim 2 shared | NHS England | £12,327,097 | 21 Dec 2020 |
| NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines shared | The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | · | 6 Jan 2026 |
| NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines shared | The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | · | 6 Jan 2026 |
| NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals shared | NHS England | · | 6 Apr 2023 |
| NHS National Generic Pharmaceuticals Interim 2 2020 shared | The NHS Commissioning Board (operating under the name of NHS England) | · | 3 Feb 2021 |